Friday, October 29, 2021

TAG

DCGI

Covaxin maker laments “fake news”, has hit our morale

Ahead of the World Health Organisation’s technical advisory group meet to consider emergency use listing of India’s indigenous Covid vaccine Covaxin, Bharat Biotech founder...

Rajiv Gandhi Trust, Gates Foundation and Lives Lost: Who’s bothered?

Throughout the pandemic, monopolist-turned-philanthropist Bill Gates and his multiple foundations were applauded for their “support,” in the production and distribution of Covid-19 vaccines. But...

Vaccination for children from August onwards, says health minister

Union Health Minister Mansukh Mandaviya has said that the government would likely begin vaccinating children for Covid-19 from August. The health minister reportedly informed...

Serum to produce Sputnik V vaccine from September onwards

The Russian Direct Investment Fund (RDIF) announced that the Serum Institute of India (SII), the world’s largest vaccine producer, will start producing Sputnik V...

AIIMS Delhi begins clinical Covaxin trials on children in 12-18 age group

AIIMS Delhi has begun screening for clinical trials of Covaxin, Covid-19 vaccine, on children from today, as per ANI.  The trial is planned on 525...

Zydus Cadila could become second Indian vaccine after Covaxin

Ahmedabad-based Zydus Cadila can become India’s second indigenously-developed jab after Bharat Biotech’s Covaxin and fourth vaccine candidate as they are likely to apply for...

Anti-Covid-19 drug would be available from early next week

The 10,000 doses of the anti-Covid-19 drug, 2-deoxy-D-glucose (2-DG), developed by the Defence Research and Development Organisation (DRDO) in association with Dr. Reddy’s Laboratories,...

DRDO develops oral drug as adjunct therapy for Covid-19 patients

The Drugs Controller General of India (DCGI) has permitted the emergency use of an oral drug, developed by the DRDO (Defence Research and Development...

India to fast-track approval of other foreign Covid-19 vaccines

Amid the increasing positive cases, the Indian government in a significant step has decided to fast-track the approvals for foreign-produced Covid-19 vaccines that have...

Covishield vaccine priced at Rs 200 per vial

Covishield vaccine manufactured by the Serum Institute of India (SII) has been priced at Rs 200 per vial. This price has been decided for...

Voices

155 POSTS0 COMMENTS
110 POSTS0 COMMENTS
Support Us
Contribute to see NewsBred grow. And rejoice that your input has made it possible.